FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/08/093584 [Registered on: 25/08/2025] Trial Registered Prospectively
Last Modified On: 08/07/2026
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug
Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   Using a nerve block to reduce pain in children undergoing tonsil removal surgery. 
Scientific Title of Study   The efficacy and safety of palatine nerve block in reducing postoperative pain and recovery time in patients undergoing conventional tonsillectomy 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Shilpa Susan Mathew 
Designation  Assistant Professor 
Affiliation  Christian Medical College,Vellore 
Address  ENT Unit II Office, CMC Hospital Campus, Vellore 632004 Phone:0416 228 2798

Vellore
TAMIL NADU
632004
India 
Phone  8098121756  
Fax    
Email  shilpa.susan@cmcvellore.ac.in  
 
Details of Contact Person
Scientific Query
 
Name  Shilpa Susan Mathew 
Designation  Assistant Professor 
Affiliation  Christian Medical College,Vellore 
Address  ENT Unit II Office, CMC Hospital Campus, Vellore 632004 Phone:0416 228 2798


TAMIL NADU
632004
India 
Phone  8098121756  
Fax    
Email  shilpa.susan@cmcvellore.ac.in  
 
Details of Contact Person
Public Query
 
Name  Shilpa Susan Mathew 
Designation  Assistant Professor 
Affiliation  Christian Medical College,Vellore 
Address  ENT Unit II Office, CMC Hospital Campus, Vellore 632004 Phone:0416 228 2798


TAMIL NADU
632004
India 
Phone  8098121756  
Fax    
Email  shilpa.susan@cmcvellore.ac.in  
 
Source of Monetary or Material Support  
Christian Medical College,Vellore,Tamil Nadu,India 632004 
 
Primary Sponsor  
Name  Christian Medical College,Vellore 
Address  Christian Medical College, Vellore 632004 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Shilpa Susan Mathew  Christian Medical College  Department of ENT, CMC hospital campus, Ida Scudder Road, Vellore-632004, Tamil Nadu
Vellore
TAMIL NADU 
8098121756

shilpa.susan@cmcvellore.ac.in 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL REVIEW BOARD,CMC VELLORE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J351||Hypertrophy of tonsils,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  PALATINE NERVE BLOCK USING 0.2% ROPIVOCAINE  Single dose of palatine nerve block using 0.2% Ropivocaine in children undergoing tonsillectomy for chronic tonsillitis. 
Comparator Agent  PALATINE NERVE BLOCK USING NORMAL SALINE   Single dose of palatine nerve block using 0.9% Normal Saline in children undergoing tonsillectomy for chronic tonsillitis. 
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  16.00 Year(s)
Gender  Both 
Details  Children under 16 years of age undergoing tonsillectomy using the dissection and snare technique for chronic tonsillitis

 
 
ExclusionCriteria 
Details  Other tonsillectomy technique
Duration of surgery more than 2 hours
All other indications for tonsillectomy other than chronic tonsillitis
Children with craniofacial abnormalities
Children with history of cleft palate repair or other palatoplasty procedures

 
 
Method of Generating Random Sequence   Permuted block randomization, fixed 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary outcome will be the level of postoperative pain, assessed using Wong Baker Faces Pain Rating Scale at regular intervals over 24 hours post surgery.   Assessment at 1 hour,4 hours,12 hours and 24 hours after surgery 
 
Secondary Outcome  
Outcome  TimePoints 
Secondary outcomes will include the time to first analgesic requirement, total analgesic consumption within 24 hours, incidence of complications, & parental satisfaction scores  Assessment at 1 hour,4 hours,12 hours & 24 hours after surgery & 1 week after surgery 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/01/2026 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)
Modification(s)  
Not Applicable 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - To achieve aims in the approved proposal.

  5. By what mechanism will data be made available?
    Response - Proposals should be directed to [shilpa.susan@cmcvellore.ac.in].

  6. For how long will this data be available start date provided 01-04-2026 and end date provided 30-04-2029?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - nil
Brief Summary  

This study will evaluate the efficacy of palatine nerve block in patients undergoing tonsillectomy. Tonsillectomy is a common surgical procedure often associated with significant postoperative pain which can delay recovery, reduce patient satisfaction and lead to complications. The palatine nerve block, targeting the greater and lesser palatine nerves, provides effective pain relief while reducing the need for systemic analgesics, minimizing side effects such as sedation and nausea and prompting early oral intake in children.

The study will adopt a prospective, randomized controlled trial design. Participants will be randomized into two groups: one receiving the palatine nerve block alongside standard care and another receiving standard care alone. Pain scores using a validated visual analogue scale will be measured post operatively at 1 hour, 4 hours, 12 hours and 24 hours postoperatively.

Data collection will be conducted over a 6-month period, with interim analyses to ensure safety and validity. Ethical approval and informed consent will be secured prior to study initiation.

By the end of the study, we will determine whether the palatine nerve block offers a safe and superior pain control compared to standard care, providing valuable insights for optimizing perioperative pain management in tonsillectomy patients.

 
Close